Mytollovid

Todos Medical Ltd. is a leading brand that specializes in engineering life-saving diagnostic solutions for the early detection of various cancers. Founded in Rehovot, Israel, with offices in New York City, the company is committed to developing innovative technologies to aid in the fight against cancer.

Their state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology that uses peripheral blood analysis to examine cancer's influence on the immune system. By looking for biochemical changes in blood mononuclear cells and plasma, Todos Medical's tests provide valuable insights into the presence of cancer.

In addition to their cancer-screening tests, Todos Medical has also acquired Provista Diagnostics, Inc., a US-based medical diagnostics company. This acquisition has granted them the rights to Provista's CLIA/CAP-certified lab, which currently performs PCR COVID testing, as well as access to the proprietary commercial-stage Videssa® breast cancer blood test.

Furthermore, Todos Medical is actively involved in developing blood tests for early detection of neurodegenerative disorders like Alzheimer's disease. Their Lymphocyte Proliferation Test (LymPro Test™) evaluates the ability of peripheral blood lymphocytes and monocytes to withstand stimulation, providing insights into diseases that result from compromised cellular machinery.

To meet the ever-evolving medical needs, Todos Medical has also formed a joint venture called 3CL Pharma, Ltd. This venture focuses on developing diagnostic tests targeting the 3CL protease, as well as innovative pharmaceutical and botanical products that address coronaviruses.

With their commitment to advancing healthcare through cutting-edge technology and comprehensive diagnostic solutions, Todos Medical is poised to make a significant impact in the field of cancer detection and treatment. For more information about their products and services, please visit their website.